![Bronwyn O'Connor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 213 128 $ al 30/09/2026
Mr. Bronwyn B. O'Connor is a President & Chief Executive Officer at Vitrolife AB. Mr. O'Connor was previously employed as a Global President-Immunodiagnostics by Thermo Fisher Scientific, Inc. /Se/ and a President-Women Health by Medtronic AB. He received his undergraduate degree from Dublin City University and an MBA from Dublin City University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VITROLIFE AB 0,02 % | 06/02/2026 | 22.363 ( 0,02 % ) | 213 128 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VITROLIFE AB | Director Ejecutivo | 01/08/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Medtronic AB | Corporate Officer/Principal | 01/08/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Vitrolife AB
 Vitrolife AB Medical SpecialtiesHealth Technology Develops, produces and markets products and systems for the preparation, cultivation and preservation of human cells, tissues and organs | Health Technology |
Medtronic AB | |
Dublin City University
 Dublin City University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
